Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update

Conference call will be held today, Thursday, November 13 at 10:00 am ET

Woburn, MA, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT) in dermatology, today reported financial results for the three and nine months ended September 30, 2025 and provided a business update.

Read more at globenewswire.com